Ligand validation:7UAM

M5L: 6-[3-(4,4-difluoropiperidin-1-yl)propyl]-4-methylpyridin-2-amine

M5L is a Ligand Of Interest in 7UAM designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7UAM_M5L_D_804	83%	27%	0.091	0.948	1.39	1.72	4	3	0	0	100%	1
7UAM_M5L_A_803	78%	29%	0.098	0.941	1.32	1.65	4	3	0	0	100%	1
7UAM_M5L_C_803	71%	32%	0.109	0.929	1.38	1.44	4	2	0	0	100%	1
7UAM_M5L_B_803	70%	30%	0.103	0.921	1.37	1.57	4	4	0	0	100%	1
7UAN_M5L_A_803	32%	16%	0.24	0.917	1.43	2.43	4	9	0	0	100%	1
7UAO_M5L_D_503	56%	24%	0.164	0.936	1.47	1.81	4	6	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.